Ligand validation:3PRJ

UDX: URIDINE-5'-DIPHOSPHATE-XYLOPYRANOSE

UDX is a Ligand Of Interest in 3PRJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3PRJ_UDX_E_501	74%	23%	0.153	0.984	0.83	2.31	-	14	0	0	100%	1
3PRJ_UDX_A_501	70%	20%	0.156	0.974	1.35	2.05	2	12	0	0	100%	1
3PRJ_UDX_B_501	69%	26%	0.151	0.967	1.13	1.82	3	11	1	0	100%	1
3PRJ_UDX_D_501	67%	27%	0.173	0.981	1.16	1.75	2	9	1	0	100%	1
3PRJ_UDX_F_501	62%	20%	0.186	0.979	1.53	1.82	2	9	1	0	100%	1
3PRJ_UDX_C_501	47%	14%	0.224	0.966	2.13	1.78	4	10	0	0	100%	1
5VR8_UDX_B_502	93%	38%	0.091	0.987	0.98	1.45	1	7	0	0	100%	1
3PTZ_UDX_A_501	89%	22%	0.109	0.99	1.2	2.02	4	13	0	0	100%	1
6C58_UDX_A_501	84%	55%	0.109	0.972	0.72	1.01	-	3	0	0	100%	1
4WNH_UDX_A_402	84%	34%	0.093	0.954	1.03	1.55	3	8	0	0	100%	0.9
6OM8_UDX_J_501	78%	39%	0.133	0.976	0.97	1.42	3	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.